Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of IV Diclofenac (DIC075V) for Pain After Abdominal or Pelvic Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Scheduled within two weeks of the screening visit to undergo abdominal or pelvic surgery~* Moderate to severe pain within 6 hours following completion of the required surgery.~Exclusion Criteria:~* Surgical procedure involves a subcostal incision.~* Chronic disease or recent cardiovascular events.~* Known allergy or hypersensitivity to the active compounds or any of the excipients used in the study.~Additional Inclusion/Exclusion Criteria May Apply

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- A (Type: EXPERIMENTAL): intravenous diclofenac dosage level 1
- B (Type: EXPERIMENTAL): intravenous diclofenac dosage level 2
- C (Type: ACTIVE_COMPARATOR): intravenous ketorolac
- D (Type: PLACEBO_COMPARATOR): placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).